Innehållet på denna webbplats är endast avsett för veterinärer eller andra professionella inom djurhälsovård.
Genom att använda denna webbplats accepterar du ovanstående.
Intervacc announces changes in the Nomination Committee
Stockholm, March 4, 2024 – The composition of the Nomination Committee in Intervacc AB (publ) (“Intervacc”) was announced in a Press Release on October 30, 2023. Due to the fact that Ulrika Enhörning, appointed by Swedbank Robur Fonder and Thomas Ehlin, appointed by...Jonas Sohlman appointed as new CEO for Intervacc
Stockholm, February 28, 2024 – The Board of Directors for Intervacc AB (publ) announces that acting CEO Jonas Sohlman has been appointed as the new CEO of Intervacc AB and assumes the position immediately. The recruitment process that the previous board...Intervacc announces changes in dates for AGM and report for the first quarter 2024
Stockholm, February 22, 2024 – The board of directors in Intervacc AB (publ) has decided to change the date for the publication of the interim report for the first quarter of 2024 to May 15, 2024, previously communicated as May 23. The board has also decided to change...Year-end report January – December 2023
The Group in summary 01/10/23 01/10/23 Full year Full year -31/12/23 -31/12/22 2023 2022 Net sales 1 626 3 884 8 015 9 684 Operating loss -20 823 -23 394 ...Invitation to conference call and audiocast in connection with the year-end report
Stockholm, February 13, 2024 – Intervacc AB (publ) will publish the year-end report 2023 on Friday 16 February 2024 at 08:30 CET. CEO Jonas Sohlman and CFO Jan Persson will present the report at a conference call and audiocast held on 16 February 2024 at 11:00 CET. If...Nyhetstjänster
